Tilray Brands, Inc. (TLRY) Gross Margin
- Gross margin · 12 months: Value 28.45%; Formula and calculation Gross profit / revenue. Period ending 2026-05-31..
Gross margin
Overview →Financial period ending 2026-05-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 28.45% | Gross profit / revenue. Period ending 2026-05-31. $260.44M ÷ $915.45M × 100 ≈ 28.45% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 260.44M USD | Gross Profit |
| Revenue | 915.45M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 655.01M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-05-31 | $260.44M | $915.45M | $655.01M | 28.45% |
| 2026-02-28 | $237.55M | $858.27M | $620.72M | 27.68% |
| 2025-11-30 | $234.61M | $837.32M | $602.71M | 28.02% |
| 2025-08-31 | $238.33M | $830.77M | $592.43M | 28.69% |
| 2025-05-31 | $240.57M | $821.31M | $580.74M | 29.29% |
| 2025-02-28 | $255.29M | $826.66M | $571.37M | 30.88% |
| 2024-11-30 | $252.67M | $829.22M | $576.54M | 30.47% |
| 2024-08-31 | $238.86M | $812.04M | $573.18M | 29.42% |
| 2024-05-31 | $223.35M | $788.94M | $565.59M | 28.31% |
| 2024-02-29 | $208.16M | $743.25M | $535.08M | 28.01% |
| 2023-11-30 | $147.07M | $700.50M | $553.43M | 20.99% |
| 2023-08-31 | $142.54M | $650.86M | $508.32M | 21.90% |
| 2023-05-31 | $146.96M | $627.12M | $480.16M | 23.43% |
| 2023-02-28 | $73.06M | $596.26M | $523.20M | 12.25% |
| 2022-11-30 | $121.83M | $602.54M | $480.71M | 20.22% |
| 2022-08-31 | $114.48M | $613.56M | $499.08M | 18.66% |
| 2022-05-31 | $116.82M | $628.37M | $511.56M | 18.59% |
| 2022-02-28 | $146.05M | $617.28M | $471.24M | 23.66% |
| 2021-11-30 | $136.68M | $589.31M | $452.64M | 23.19% |
| 2021-08-31 | $139.19M | $563.62M | $424.43M | 24.70% |
| 2021-05-31 | $123.18M | $513.09M | $389.90M | 24.01% |
| 2021-03-31 | $27.29M | (m) | $179.11M | (m) |
| 2021-02-28 | $128.49M | (m) | (m) | (m) |
| 2020-12-31 | $24.66M | (m) | $185.83M | (m) |
| 2020-12-30 | $24.66M | (m) | (m) | (m) |
| 2020-11-30 | $123.91M | (m) | (m) | (m) |
| 2020-09-30 | $-47.82M | (m) | (m) | (m) |
| 2020-08-31 | $110.44M | (m) | (m) | (m) |
| 2020-06-30 | $-35.70M | (m) | (m) | (m) |
| 2020-05-31 | $96.05M | $405.33M | $309.27M | 23.70% |
| 2020-03-31 | $-18.01M | (m) | (m) | (m) |
| 2020-02-29 | (m) | (m) | (m) | (m) |
| 2019-12-31 | $-23.50M | (m) | (m) | (m) |
| 2019-11-30 | (m) | (m) | (m) | (m) |
| 2019-09-30 | $36.65M | (m) | (m) | (m) |
| 2019-08-31 | (m) | (m) | (m) | (m) |
| 2019-06-30 | $23.86M | (m) | (m) | (m) |
| 2019-05-31 | $43.51M | $179.30M | $135.79M | 24.27% |
| 2019-03-31 | $15.76M | (m) | (m) | (m) |
| 2018-12-31 | $14.28M | (m) | (m) | (m) |
| 2018-09-30 | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) |
| 2018-03-31 | $12.51M | (m) | (m) | (m) |
| 2017-12-31 | $11.38M | (m) | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) |
| 2016-12-31 | $2.67M | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |